Edition:
India

Onconova Therapeutics Inc (ONTX.OQ)

ONTX.OQ on NASDAQ Stock Exchange Capital Market

1.77USD
19 Jan 2018
Change (% chg)

$-0.12 (-6.35%)
Prev Close
$1.89
Open
$1.92
Day's High
$1.94
Day's Low
$1.70
Volume
50,401
Avg. Vol
50,129
52-wk High
$3.88
52-wk Low
$1.21

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.11 -0.707
Jun '17 0.32 -0.287
Mar '17 0.21 -1.232
FY 2016 Dec '16 0.17 -0.804
Sep '16 1.65 -0.294
Jun '16 2.25 -1.964
Mar '16 1.47 -2.650
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 3 1.84 5.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 1 -0.64 -0.64 -0.64 -0.44
Quarter Ending Jun-18 1 -0.40 -0.40 -0.40 -0.46
Year Ending Dec-18 3 -2.01 -1.94 -2.06 -1.93
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. -- 40.98 46.03
P/E Low - Last 5 Yrs. -- 23.80 24.39
Beta 0.14 0.90 0.89
Price to Sales (TTM) 7.31 3.98 5.45
Price to Book (MRQ) -- 4.82 5.38
Price to Tangible Book (MRQ) -- 5.57 6.89
Price to Cash Flow (TTM) -- 23.02 23.43
% Owned Institutions 26.87 1.23 2.16

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.35 5.23
Payout Ratio(TTM) -- 45.67 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -85.59 3.59 9.01
Sales (TTM) vs TTM 1 Yr. Ago -84.22 4.69 5.44
Sales - 5 Yr. Growth Rate 30.12 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago 85.38 16.23 19.33
EPS (TTM) vs TTM 1 Yr. Ago 21.60 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 1.62 2.88 2.97
LT Debt to Equity (MRQ) -- 9.81 12.10
Total Debt to Equity (MRQ) -- 13.80 16.38
Interest Coverage (TTM) -- 36.25 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.13 54.76
Gross Margin - 5 Yr. Avg. -- 52.41 52.45
EBITD Margin (TTM) -998.77 -- --
EBITD - 5 Yr. Avg -282.89 18.54 15.33
Operating Margin (TTM) -1,002.80 14.40 7.60
Operating Margin - 5 Yr. Avg. -285.00 14.46 10.79
Pre-Tax Margin (TTM) -761.54 14.82 8.38
Pre-Tax Margin - 5 Yr. Avg. -290.16 14.77 11.19
Net Profit Margin (TTM) -762.13 11.09 4.70
Net Profit Margin - 5 Yr. Avg. -290.86 11.11 7.50
Effective Tax Rate (TTM) -- 23.16 23.05
Effective Tax Rate - 5 Yr. Avg. -- 23.40 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 102,522 948,195,516 855,725,045
Net Income/Employee (TTM) -781,348 111,561,295 100,665,187
Receivable Turnover (TTM) 1.98 5.61 5.76
Inventory Turnover (TTM) -- 2.57 3.34
Asset Turnover (TTM) 0.15 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -111.27 11.41 10.97
Return on Assets - 5 Yr. Avg. -73.07 12.98 12.39
Return on Investment (TTM) -307.64 14.84 14.40
Return on Investment - 5 Yr. Avg. -96.91 16.97 16.20
Return on Equity (TTM) -4,335.58 16.32 16.09
Return on Equity - 5 Yr. Avg. -- 18.05 17.53
  1 Year 3 Year 5 Year
Sales % -51.59 5.28 30.12
EPS (TTM) % 57.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Onconova Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 22.94%
# of Holders: 19
Total Shares Held: 2,470,566
3 Mo. Net Change: -274,802
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 2
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.